
Christopher Nevala-Plagemann
Physician · St. John’s Medical Center
Credentials: · · ·
History
- 2023–Present
Research
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Review · Nature Reviews Clinical Oncology · 2020 · First of 3 authors · 304 citations
KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma
JAMA Network Open · 2025 · 33 citations
Case report · Journal of the National Comprehensive Cancer Network · 2021 · 25 citations

19 papers

9 papers

3 papers · 3 as a fellow

3 papers · 1 as a resident

3 papers

3 papers · 3 as a resident
- AS
2 papers

2 papers
Clinical trials
- 2025–2029
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Principal investigator · Recruiting · Phase 2
University of Utah
- 2023–2025
Principal investigator · Completed · Phase 2
Theriva Biologics SL
- 2025–2028
Site PI · Recruiting · Phase 1
Coherus Oncology, Inc.
- 2024–2027
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)



